Chineseinvestors Com Inc (OTC:CIIX)

SAN GABRIEL, Calif., March 9, 2020 /PRNewswire/ -- ChineseInvestors.com, Inc. (OTCQB: CIIX), an established financial news and investment portal, as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced that its former China-based subsidiary, CBD Biotechnology Co. Ltd., now known as Hemp Logic, Inc. ("Hemp Logic" or the "Company"),** is expanding its industrial hemp-infused product line to include skin-friendly antimicrobial products, including a Hemp-Infused Personal Area Spray and a Hemp-Infused Hand Sanitizer.

Unlike other basic, alcohol-based skin disinfectant products that seem to have a drying effect on the skin, in addition to the 75% alcohol base, both new products contain hemp leaf extract, which is believed to provide moisture and antimicrobial activity.  

In addition to hemp seed oil and alcohol, the Company's lead product, its Hemp-Infused Personal Area Spray, also contains aloe and a blend of Chinese herbs. A light mist of this novel Personal Area Spray provides a breathable film that is believed to effectively isolate dust, pm 2.5 pollution, bacteria, smoke, and other airborne toxins from penetrating the skin for up to 4 hours. In addition to protecting the skin, this Personal Area Spray can be used on clothing and other personal items.

Company research indicates that there are currently no other products containing this particular formula on the market in China. The Company has already received clearance to market the hemp-infused hand sanitizer from the CFDA in Shanghai and has obtained the preliminary examination certification from the same agency to produce the hemp-infused Personal Area Spray. This application process is expected to be completed within a couple of weeks.

"As it seems that the use of hand sanitizers and other personal protection supplies has become a way of life in light of the Coronavirus, the Company is working quickly to meet the current demand for safe, effective, antimicrobial  products," said Summer Yun, CEO of the Company.

SAN GABRIEL, Calif., Nov. 11, 2019 /PRNewswire/ -- ChineseInvestors.com, Inc. (OTCQB:CIIX) ("CIIX" or "the Company"), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today provides a second quarter update for FY 2020 from its Executive Team.

Two decades ago, we started down a path to build our financial news and education business from the ground up, and over the years, we believe the Chinese-speaking community has come to rely on ChineseInvestors.com, Inc.to deliver this information through new and innovative products and offerings. This is evidenced by our shareholder loyalty and support over the years.

Typical of many developing companies, revenue comes at the expense of profitability. Overall revenues increased 175% to $6,476,442 for the year ended May 31, 2019 from $2,353,331 in the year ended May 31, 2018. This was largely attributed to the Company's subsidiary in China, CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands ("CBD Biotech). In addition, our core business of financial news/education and investor relations, which targets the Chinese-speaking community, is very strong. Although our revenue growth has been impressive, we believe our stock price has been affected as a result of our net loss; therefore, we are refocusing and prioritizing our core business.

Given our proficiency at spotting trends in niche markets and using that information to stay ahead of the competition, we were and will continue to be on the forefront of the industrial hemp/CBD market. Currently, we are excited about initial market tests for a hemp-infused wrinkle cream that will launch soon in China. As product margins seem to be healthier in this market, the Company's main focus for its industrial hemp business in FY 2020 will be on its China operations where we have a robust product development pipeline. While cannabis use in China is illegal, cannabis-based oils including industrial hemp extract may be added to cosmetics, thus opening a potential market of nearly 1.4 billion people for the Company. As we analyze the legality/trends in other Asian countries, we have an advantage with "feet on the ground" in that part of the world.

With regard to our other CBD business in the U.S., although the U.S. market has experienced some favorable changes in the law related to industrial hemp/CBD, there has been some volatility, which can be a consequence of entering a nascent market. With confidence that the U.S. Market will rebound, the Company intends to continue invest conservatively in its U.S. hemp/CBD operations focusing on organic growth.

On the financial side of the business, we are in the process of establishing a working cooperation with a private equity firm in China. Given the loyalty to our brand in China, we would expect this relationship to have a positive impact on our investor relations business globally.  In addition, we have a minority interest in a U.S.-based investment bank, Donald Capital, LLC. Both of these relationships are projected to be a source of recurring revenues for years to come. At the same time, in an effort to cut costs, the Company made cuts across departments dedicated to cryptocurrency and is now bundling its remaining cryptocurrency subscriptions with other core subscription offerings. We will also continue to look for other ways to streamline business operations and maximize current resources across the board.

As we reflect on two decades of business, we have laid the foundation that has allowed us to make strategic investments and achieve rapid growth. Looking forward, we will concentrate on the rewarding opportunities that we have identified for ChineseInvestors.com and our valued shareholders, including the continued growth our core business, and continued diversification of our revenue streams through our industrial hemp-infused/CBD products in China and the U.S., which we believe will lead to increased revenues and improved profitability. Although we still have work to do this regard, with these objectives in mind, with a dedicated and experienced management team, and most importantly, the continued support of our loyal shareholders we look forward to a healthy FY 2020.

SAN GABRIEL, California, Oct. 17, 2019 /PRNewswire/ -- ChineseInvestors.com, Inc. (CIIX) ("CIIX" or "the Company"), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced its financial and operational summary for the First Quarter of its Fiscal Year 2020.

Q1 Fiscal Year 2020 Financial Highlights

Total revenue for Q1FY2020 was $1,956,960, a 174.7% increase from $712,360 for the same quarter in the prior year.
Hemp and CBD sales revenues for Q1FY2020 were $948,751, a 569.2% increase from $141,764 for the same quarter in the prior year.
Although subscription revenues were slightly down $186,452, a 17.6% decrease from $226,312 for the same quarter in the prior year, largely attributable to the suspension of some of the Company's paid cryptocurrency subscription offerings, the Company's investor relations revenues for Q1FY2020, were $821,361, an improvement of 200%+ from $271,248 for the same quarter in the prior year.
"Fiscal Year 2020 is off to a great start evidenced by continued growth in both the Company's core business and its industrial hemp/CBD product business. Following the 2018 cryptocurrency crash, the Company re-focused on its core business, including providing investor relations services for other companies, especially those requiring Mandarin language support, and continued to implement its strategic plans for expansion of CBD Biotechnology Co. Ltd.'s, industrial hemp/CBD product lines in China evidenced by new product launches and initiatives taken to expand geographically in the Asian market," said Mr. Warren Wang , CEO of ChineseInvestors.com, Inc.

The net loss from operations for Q1FY2020 was $2,645,717.

SAN GABRIEL, California, Sept. 3, 2019 /PRNewswire/ -- ChineseInvestors.com, Inc. (CIIX) ("CIIX" or "the Company"), a premier provider of financial news and education for the Chinese-speaking community, today provided an update on its financial results for the fiscal year ended May 31, 2019 and outlook for fiscal year 2020. 

The Company reported a 175% year-over-year increase in revenue for FY 2019.

The Company reported overall revenue of $6.5 million, up from $2.4 million in FY 2018, largely attributed to a $3.8 million increase in sales revenue from industrial hemp and CBD liquor products, including new products introduced in China by the Company's subsidiary, CBD Biotech, Inc.

Revenue Highlights:

• $4,189,935 in sales revenue from industrial hemp and CBD liquor products in FY 2019, up from $378,984 in FY 2018;
• $1,336,402 in investor relations revenues in FY 2019, up from $968,282 in FY 2018; and
• $865,457 in subscription revenues in FY 2019, up from $779,964 in FY 2018.

"We have seen significant growth in revenues this year, primarily attributable to the Company's CBD consumer products line in Asia," stated Mr. Warren Wang CEO of Chineseinvestors.com. "While we have been strategically focusing on industrial hemp and CBD sales, we are pleased with the progress we have seen in our legacy businesses, financial news, education subscriptions, and investor relations, where we are re-focused on organic growth. We expect to see the full result of these efforts in FY 2020."

The results of the Company's operations through May 31, 2019 are set forth completely in the Company's Form 10-K annual report as filed with the SEC on August 27, 2019 and can be accessed at ChineseInvestors.com.

SAN GABRIEL, California, April 29, 2019 /PRNewswire/ --ChineseInvestors.com, Inc. (OTCQB: CIIX), an established financial news and investment portal, and a leading industrial hemp/CBD retailer to the global Chinese-speaking community, today announced that its wholly owned subsidiary, ChineseHempOil.com, Inc. dba Chinese Wellness Center ("CWC") will launch a pop-up kiosk in the Glendale Galleria mall, located in Glendale, California, beginning May 1, 2019. The pop-up kiosk will carry various industrial hemp/CBD products, including CWC's own OptHemp product line.

"We are excited to bring our brand directly to the shoppers in the Greater Los Angeles area," says Mr. Warren Wang, Chief Executive Officer of ChineseInvestors.com, Inc. "Building on the current success of CWC's industrial hemp/CBD product offerings, this pop-up kiosk will allow us to further engage with our local consumers beyond our online presence."

The CWC pop-up kiosk will be located on the first floor of the Glendale Galleria Mall. The kiosk will sell industrial hemp/CBD products, including NuLeaf Naturals, Joy Organics, MedTerra, Hemp Meds, Medix, and CWC's own OptHempproducts.  CWC will introduce special offers, promotions and giveaways for Glendale Galleria customers.

CWC has been operating in the United States since 2017 as one of the first companies to promote and sell industrial hemp/CBD products to the domestic Chinese-speaking  community.  CWC is constantly looking for new and innovative ways to promote wellness in the Chinese community and is dedicated to offering the best personal wellness products and solutions to its customers.

SAN GABRIEL, California, March 4, 2019 /PRNewswire/ -- ChineseInvestors.com, Inc. (CIIX) (the "Company"), a premier provider of financial news and education for the Chinese-speaking community today announced that its Board of Directors has appointed Patrick Leung Chief Financial Officer ("CFO") effective March 1, 2019.

CEO Warren Wang comments, "We are delighted to appoint Mr. Leung as our CFO.  Mr. Leung has been an active board member of ChineseInvestors.com, Inc. for the past two years, is very familiar with the operations and financial positioning of the Company, and comes to us with a rich global experience.  We are also grateful to Alex Hamilton for stepping in as the Interim CFO during this transition.  Mr. Hamilton will continue to serve as the CFO for CBD Biotechnology Co. Ltd., the Company's wholly owned foreign entity, and will be vital in planning the much anticipated spinoff of CBD Biotechnology Co. Ltd."

Mr. Leung is a Certified Public Accountant in both Australia and Hong Kong.  He comes to ChineseInvestors.com, Inc. from Kirin Group Holdings Limited where he served as the Executive Director and Company Secretary.  Mr. Leung has over two decades of experience, serving in various executive and directorial roles at a number of companies listed on the Stock Exchange of Hong Kong and NASDAQ, including Biostar Pharmaceuticals, Inc., Hao Wen Holdings Limited and Celebrate International Holdings Limited.  He has also served as an auditor for Armando Y C Chung & Company and Deloitte Touche Tohmatsu Limited. Mr. Leung earned his Bachelor of Commerce (Accounting & Finance) from Deakin University in Victoria, Australia in 1996.

SAN GABRIEL, California, Feb. 19, 2019 /PRNewswire/ -- ChineseInvestors.com, Inc. (OTCQB: CIIX) (the "Company"), an established financial news and investment education portal, and a leading industrial hemp retailer for the domestic Chinese-speaking community, today announced the completion of its rebranding of ChineseHempOil.com, Inc.'s consumer product line under the new opt brand. In conjunction with the rebranding, the Company announces the consolidation of its retail e-commerce sites into a single site, www.365CWC.com, providing busy consumers with a single platform intended drive overall sales. www.365CWC.com officially launches today.

 As part of the rebranding, the Company  will feature the following product lines:

opt Hemp which includes products infused with industrial hemp-derived CDB, such as the currently offered gummies, oils, soft gels and tinctures, and topical, cosmetics and other hemp-derived CBD products in development that will compliment this line.
opt2mist™ an innovative spray vitamin product line which will also feature full spectrum hemp-derived CBD-infused formulas.
The Company's wholly owned foreign entity, CBD Biotechnology Co. Ltd. ("CBD Biotech") has its own product lines specifically designed for the Chinese market abroad including CBD Biotech's skincare lines, the Live Oxygen Series, featured on Alibaba's Tmall online store and its Magic Hemp Series featured on Alibaba's Taobao Platform, China's largest e-commerce marketplaces for brands and retailers, with over 500 million registered customers, in addition to its self-branded hemp-infused rice wine, CBD Biotech Hemp Wine. 

"The unification  of our domestic consumer products under the opt brand, is a step in the right direction to building optimal brand recognition as we continue to roll out new industrial hemp-infused CBD products and other health and wellness products, such as the opt2mist sprays, throughout 2019 and beyond. When visiting www.365CWC.com, consumers will be greeted with an entirely new consumer experience in terms of brand appeal, user functionality and customer service. The consolidation of our domestic consumer sites into a single channel will provide a one-stop shop for busy consumers which, in turn, we believe will ultimately drive sales, " says the Company's CEO Warren Wang.

SAN GABRIEL, California and SHANGHAI, China, December 27, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), a financial information website for Chinese-speaking investors, today announced that it has retained Boustead Securities, LLC as underwriter for the planned Initial Public Offering ("IPO") of its wholly owned foreign enterprise, CBD Biotech Co. Ltd. ("CBD Biotech"), concurrently with a listing on a national securities exchange.

Mr. Warren Wang, Founder, CEO and Chairman of Chinese Investors.com, commented, "This is part of a series of actions we have put into place to execute on our strategic plan to spin-out CBD Biotech. Additionally, we believe that listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy. We look forward to working with Boustead Securities as IPO sponsor and underwriter."

Boustead Securities' Dan McClory, Managing Director, Head of China, and Head of Equity Capital Markets, stated, "We believe CBD Biotech can potentially gain a first mover advantage in the Chinese CBD market, and could be well received in the public markets. Boustead looks forward to supporting CBD Biotech's growth mission with capital through the planned IPO and national exchange listing."

SAN GABRIEL, California, December 18, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced the appointment of Alex Hamilton, as Chief Financial Officer of its wholly-owned subsidiary, CBD Biotechnology, LTD. Mr. Hamilton's focus will be on the execution of the previously announced spin-off of CBD Biotech, as well as overseeing a variety of corporate functions, including accounting, business operations and pricing, financial planning and analysis, financial reporting, investor relations, internal Audit, SEC reporting, tax and treasury functions.

"I am humbled by this appointment and look forward to unlocking a lot of value with the spin-off," says Mr. Hamilton. "This is an exciting opportunity with rapid growth, a first-to-market advantage and a way to benefit to from the largest market ever, the Chinese mainland population."

Through Mr. Wang's continued leadership as CEO of CIIX, Mr. Hamilton's leadership as the CFO of CBD Biotechnology coupled with Summer Yun's leadership as the CEO of CBD Biotechnology, the Company hopes to refocus on its core financial services/media business. Mr. Hamilton has spent the previous five years as an consultant, serving as Founder and CEO of Hamilton Strategy Group.

"We are all energized by the appointment of Alex Hamilton as the CFO of CBD Biotech," says Mr. Wang. "Mr. Hamilton is a seasoned financial executive, a veteran of Wall Street with over 20 years of experience, strategic advisor, entrepreneur and investor. I am confident he will lead the company through a seamless transition and beyond."

SAN GABRIEL, California, December 18, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced the appointment of Alex Hamilton, as Chief Financial Officer of its wholly-owned subsidiary, CBD Biotechnology, LTD. Mr. Hamilton's focus will be on the execution of the previously announced spin-off of CBD Biotech, as well as overseeing a variety of corporate functions, including accounting, business operations and pricing, financial planning and analysis, financial reporting, investor relations, internal Audit, SEC reporting, tax and treasury functions.

"I am humbled by this appointment and look forward to unlocking a lot of value with the spin-off," says Mr. Hamilton. "This is an exciting opportunity with rapid growth, a first-to-market advantage and a way to benefit to from the largest market ever, the Chinese mainland population."

Through Mr. Wang's continued leadership as CEO of CIIX, Mr. Hamilton's leadership as the CFO of CBD Biotechnology coupled with Summer Yun's leadership as the CEO of CBD Biotechnology, the Company hopes to refocus on its core financial services/media business. Mr. Hamilton has spent the previous five years as an consultant, serving as Founder and CEO of Hamilton Strategy Group.

"We are all energized by the appointment of Alex Hamilton as the CFO of CBD Biotech," says Mr. Wang. "Mr. Hamilton is a seasoned financial executive, a veteran of Wall Street with over 20 years of experience, strategic advisor, entrepreneur and investor. I am confident he will lead the company through a seamless transition and beyond."

SAN GABRIEL, California, December 4, 2018 /PRNewswire/ --

LOI Covers Exclusive License for the Global Asian Market for VitaMist Products and Development of and License to Sell a New Sprayable Vitamin and Vitamin/CBD Product Line Designed Exclusively for ChineseInvestors.com, Inc. for the Global Asian Market

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or "the Company"), a premier provider of industrial, hemp-derived CBD products and other hemp health products for the global Chinese community, today announced that it recently executed a letter of intent to acquire exclusive rights to all sales channels for the VitaMist product line (retail, online, MLM) in Asian markets domestically and internationally. As part of the proposed licensing agreement, BCDBG, Inc. will also develop an exclusive product line, for ChineseInvestors.com, Inc. designed with the global Asian Market in mind, including vitamin only sprays and vitamins/CBD spray combinations. In furtherance of the anticipated agreement, the Company has placed initial product orders with BCDBG, Inc. for VitaMist products. The timing of this agreement for licensing and product development is critical as some industry leaders believe that a final farm bill, including provisions for the legalization of industrial hemp at a federal level, is expected to reach completion this week or by the end of the year.

BCBDG, Inc. recently acquired VitaMist Ltd. and Mayor Pharmaceutical Laboratories, Inc., known for their development and distribution of spray delivery vitamins, with over 30 years in the industry and over three million individual product sales. VitaMist Ltd. was awarded the first patent ever for a spray vitamin in 1985.

"The licensing agreement with BCBDG, Inc. will be a significant development for ChineseInvestors.com, Inc.'s consumer division as we expand our product line globally and capitalize on VitaMist's innovative spray technology, over 40 proprietary vitamin formulas, its brand recognition and its longevity in the industry. We truly believe VitaMist's innovative and effective delivery system is the future for CBD consumption." says ChineseInvestors.com, Inc.'s CEO, Warren Wang.

Wang continues, "With South Korea becoming the first East Asian country to legalize marijuana for medical purposes, and with hopes that Thailand will soon follow, this is an exciting time for the global cannabis industry as well. We look forward to more opportunities such as this licensing offer as we expand our reach into global industrial hemp industry."

"Given VitaMist's superior spray delivery system, its precise dosing methodology, its large catalog of proprietary formulations, and ChineseInvestors.com, Inc.'s focus on the Asian consumer market, we believe this proposed licensing agreement with ChineseInvestors.com, Inc. is a grand slam!" states VitaMist CEO Richard Heineck.

NEW YORK, July 17, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces the official launch of its new cryptocurrency trading courses offered through its newly established Bitcoin Trading Academy LLC.

The Company officially launched the following three part course offering on July 7, 2018:

Bitcoin Trading 101: Students are provided with a basic knowledge about Bitcoin including how to open and trade on different cryptocurrency trading platforms, how to set up a cryptocurrency wallet, futures trading strategies, both long and short, how to use Bitcoin Futures to properly hedge one's Bitcoin portfolio, and how to properly use beginner-friendly trading techniques.

Bitcoin Trading 201: The second course in the program focuses on coins such as Ethereum, including coins with significant underlying technology such as EOS, XLM, ADA and NEO, and altcoin trading platforms, such as Binance and Bittrex. In addition, this course will provide instruction on how to use information such as a coin's underlying utility, current industry and sector news in combination with technical analysis in an effort to maximize returns; and effectively scrutinize and understand social media feeds.

Bitcoin Trading 301: Professional ICO analysts will teach students what to look for when vetting a new cryptocurrency offering, including how to read a white paper, analyze the professional teams and advisory boards associated with an offering, the role that technology, marketing, trends play and what pitfalls to avoid.

"We are pleased with the turn out for the first live course offerings in New York City and we expect even better attendance once the word spreads about this innovative cryptocurrency education opportunity. Courses are also offered online in English and Chinese. In addition, the Company plans to expand its live course offerings to Asia in the coming months," says ChineseInvestors.com, Inc. CEO Warren Wang. 

NEW YORK, June 5, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced that it has entered into a licensing partnership with The Bad Crypto Podcast to re-distribute the podcast's most popular interviews on http://www.newcoins168.com , in Chinese. 

Interviews that will be translated into Chinese for re-distribution on http://www.newcoins168.com include: Charlie Lee, Founder and Developer of Litecoin, Roger Ver, also known as 'Bitcoin Jesus', and Patrick Bryne, Overstock.com CEO and Founder of tZERO. In addition to re-distributing these informative interviews in Chinese, the Company's CEO Warren Wang also appeared once again for an interview on The Bad Crypto Podcast on May 23, 2018. Mr. Wang first appeared on The Bad Crypto Podcast in December 2017 where he offered his perspective and insights on bitcoin and cryptocurrency in China. 

"Since it first aired in July 2017, The Bad Crypto Podcast hosted by Joel Comm, Bitcoin Evangelist and Travis Wright, Blockchain Entrepreneur, has become a worldwide phenomenon with over 150 episodes for curious individuals trying to figure out cryptocurrency, blockchain and the future of digital payments," says ChineseInvestors.com, Inc. CEO Warren Wang. "We are confident that this lighthearted, entertaining programming offered in Chinese will be well received by viewers looking to expand their crypto knowledge whether they are newbies or more experienced crypto investors." 

NEW YORK, May 21, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced that its wholly owned subsidiary, ChineseHempOil.com, Inc. ("ChineseHempOil") has expanded its domestic sales force appointing Nina Wang Vice President of Sales for its United States Consumer Retail/E-Commerce Division on March 19, 2018, setting the stage to complete the temporarily postponed spin off of all of the Company's hemp related assets in the near future.

Mrs. Wang has over 15 year's sales experience in the financial services industry with over 10 years as a Merchant Services Sales Manager at USA First Credit Card, Inc. Prior to that, Mrs. Wang worked as a Sales Manager for Alliance Bank Card Services.  Since joining ChineseHempOil.com, Inc. in March 2018, Mrs. Wang has hired a team of sales representatives focused on wholesale and consignment sales in the Los Angeles area. 

Through her efforts, ChineseHempOil.com, Inc. has developed strategic relationships with over 70 retail establishments in the Los Angeles area to consign the ChineseHempOil OptHemp products with plans to expand to Northern California in the near future.  Mrs. Wang will also play an integral role in procuring new manufacturing relationships to, continuing to brand the Opt Hemp product line and developing new cutting edge hemp products.

"With over 15 years sales and management experience, we look forward to the increased sales that will be generated through Mrs. Wang's leadership as we are laying the groundwork to increase revenues in advance of the spin-off of all of the Company's hemp related assets.  We were pleased with the 57% increase in monthly sales generated by the recent Mother's Day Promotion and are looking forward to an even better response for the Father's Day promotion" said Warren Wang CEO.

The Company recently announced in an 8k filing that spin-off of all of the Company's hemp related assets, originally scheduled for May 31, 2018, has been temporarily postponed as it continues to develop its domestic sales channels.

NEW YORK, May 14, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces the launch of its cryptocurrency and blockchain talk show entitled "Bitcoin Talk Show" airing on Phoenix North America Chinese Channel ("Phoenix North America"). This innovative television program will begin airing the first week of June 2018. Local Chinese investors and business owners will be invited to the Phoenix North America headquarters to attend the live taping where they will discuss cryptocurrency and blockchain technology with the Company's Newcoins168.com Analysts.

"We believe Chinese investors are seeking cutting edge knowledge about blockchain and cryptocurrency, and this lighthearted, entertaining television program will accomplish just that. In addition, we seek to bring awareness to the newcoins168.com brand and to gain recognition as a leader in Chinese language cryptocurrency and blockchain education," says Warren Wang, CEO of ChineseInvestors.com, Inc.

ChineseInvestors.com, Inc. and Phoenix North America have entered into a one year contract to air the 22-minite Bitcoin Talk Show, once monthly. The pre-recorded talk show will be broadcasted to audiences in North America and will also be aired on the ChineseFN and Newcoins168.com YouTube channels. Recently Phoenix North America was added to the list of free channels offered by Time Warner Cable, which will provide exposure to over 500,000 Chinese people domestically.

"With the 2017 launch of Bitcoin Multimillionaire, the first daily cryptocurrency video newscast broadcast from the NYSE in the Chinese language, and http://www.newcoins168.com , and the upcoming launch of the Bitcoin Trading Academy and Bitcoin Talk show in June 2018, we are implementing our strategic plan to provide Chinese investors with essential cryptocurrency investment education and trading tools," says Wang.

"As the Company continues its expansion into the cryptocurrency space, we anticipate a 30% increase in revenues from last year, resulting in three consecutive years of revenue growth since 2016. This is an exciting time for ChineseInvestors.com, Inc. as the Company's fiscal year comes to an end on May 31, 2018." Wang concludes.

SAN GABRIEL, California, April 30, 2018 /PRNewswire/ --

ChineseInvestors.com Inc. (CIIX)("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces new cryptocurrency and trading courses offered through its newly established Bitcoin Trading Academy LLC beginning in June 2018.

The Bitcoin Trading Academy's course offering will include:

Bitcoin Trading 101: Students will gain basic knowledge about Bitcoin including how to open trading accounts on the most commonly held cryptocurrency trading platforms how to set up a cryptocurrency wallet. In addition, students will be educated on Bitcoin Futures trading strategies, both long and short, how to use Bitcoin Futures to properly hedge one's Bitcoin portfolio, and how to properly use beginner-friendly trading techniques trading techniques such as Candlesticks and Moving Averages, among other key metrics that top financial analysts use in trading assets.

Bitcoin Trading 201: The second course in the program will focus on coins such as Ethereum, including coins with significant underlying technology such as EOS, XLM, ADA and NEO, and altcoin trading platforms, such as Binance and Bittrex. In addition, this course will provide instruction on how to use information such as a coin's underlying utility, how to use current industry and sector news in combination with technical analysis in an effort to maximize returns; and how to effectively scrutinize and understand social media feeds.

Bitcoin Trading 301: Professional ICO analyst, Preston Hom, will teach students what to look for when vetting a new cryptocurrency offering, including how to read a white paper, how to analyze the professional teams and advisory boards associated with an offering, the role that technology, marketing, trends play and what pitfalls to avoid.

"We are excited to expand our cryptocurrency education platform with the launch of Bitcoin Trading Academy, a cutting-edge cryptocurrency trading education center which follows the Company's successful November 2017 launch of newcoins168.com, a Chinese language cryptocurrency and blockchain technology news and information site. In addition to online courses, Bitcoin Trading Academy will offer live courses in New York City," says ChineseInvestors.com, Inc. CEO Warren Wang. 

San Diego, March 22, 2018 (GLOBE NEWSWIRE) -- Investors are excited to hear what ChineseInvestors.com, Inc. (CIIX) said about its big moves into the blockchain space on Investor Town Hall Show. ChineseInvestors.com, the premier financial information website for Chinese-speaking investors, commissioned additional revenue streams with ASIC mining machines that generate both Bitcoin and Litecoin.

CIIX is seeing tremendous upside and opportunity for growth in a sector that is expected to grow to $2.3 billion USD by 2021 according to FinTech firm Statista. 

The mining operation complements CIIX’s blockchain business strategy by adding to top-line revenue growth. As the company begins educating its subscribers on trading crypto on its other Chinese-investor-targeted media platform, NewCoins168.com, the plan is cross-pollinating new crypto revenue streams into its existing products and services. On May 1st investors will be able to enroll in online cryptocurrency trading academy that CIIX is adding to NewCoins168.com’s platform to learn about trading Bitcoin futures, alt coins, technical analysis and investing in ICOs.

ChineseInvestors.com is proud to provide Chinese-speaking investors here in the US the knowledge to take advantage of the cryptocurrency upside potential, while educating them on the risks and rewards.

Wang says the goal is to double or triple the company’s revenue every year by making more synergistic investments into revenue streams that add more value to the company by creating subscription products called “Cryptocurrency VIP Club.” He explains more about it in the interview.

SAN GABRIEL, California, March 19, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that it is exploring investments into Cryptocurrency Mining with its recent purchase of ASIC (Application Specific Integrated Circuit) machines used to mine SHA-256 or Scrypt mining algorithms to earn cryptocurrencies such as Bitcoin and Litecoin. 

The Company's initial trial included the purchase of 20 BitMain L3+ Antminers and 7 BitMain S9 AntMiners that were installed inside a top of the line and secured datacenter near Seattle. Based on initial reports, the Company anticipates that this will be a successful venture that will open the door for the Company to consider adding 500 or more ASIC units and to make an additional investment in graphical processing units ("GPUs") and other equipment suitable for blockchain mining that can achieve minimum hash rates consistent with the equipment specifications by the end of its fiscal year, May 31, 2018.

According to ChineseInvestors.com, Inc.'s CEO Warren Wang, "this initial step into cryptocurrency mining positions the Company to capitalize on a growing industry which could have tremendous upside potential. Moreover, the knowledge that CIIX is gaining and the professional contacts it is developing in the cryptocurrency space is synergistic with the educational content the Company provides subscribers on its crypto news platform, NewCoins168.com.

"The Company endeavors to be on the cutting edge of blockchain technology and to stay ahead of the curve in an effort to continue to build shareholder value and increase revenues this year."

NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ChineseInvestors.com, Inc. (CIIX), a client of NNW recognizing unprecedented opportunities in the U.S. cannabis industry and laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

To view the full publication, titled “Hemp Provides Investors Access to Larger Cannabidiol Market,” visit: LINK

Its position at the intersection of American and Chinese markets has put CIIX in a perfect position to explore the wider cannabidiol market. Marijuana use is illegal in China, but CBD oils, including hemp-based CBDs, are legal. CIIX is committed to developing and distributing hemp-based products in hopes of helping people improve their overall health, targeting epilepsy, Alzheimer’s disease, cirrhosis of the liver and various other health conditions. With nearly 10 million epilepsy patients in China, products that can help these customers have the potential to become big sellers in a growing market.

In December 2016, CIIX reached a wholesale agreement with a CBD health brand. Off the back of this, it launched its new subsidiary ChineseCBDoil.com. This website went live on Jan. 31, 2017, providing the world’s first Chinese language online store for CBD health products. It provides a variety of nutritional supplements containing CBD, including soft gels, capsules and concentrates available to Chinese-speaking customers worldwide.

SAN GABRIEL, California, February 5, 2018 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for the Chinese-speaking investors, today announced that its wholly-owned foreign enterprise CBD Biotechnology Co. Ltd. ("CBD Biotech") will launch 4 new hemp infused skin care products and a cutting-edge magnetic mask for the China Market in February 2018. The products have been approved for sale in China by the China Food and Drug Administration ("CFDA"). In November 2017, CBD Biotech launched its successful CBD Magic Hemp Series, an affordable hemp-infused skincare line which gained huge recognition thanks to the online beauty influencer, The Godfather of Beauty. 

CBD Biotech follows this successful product introduction with the launch of the new 'Live Oxygen' series, a luxury skincare line that uses nanotechnology to penetrate the skin more effectively and is designed to maximize anti-aging effects and to restore the skin's youthful glow. These products are designed to be safe for all skin types. The line includes:

- The CBD Bio Tech Live Oxygen Cleanser, a gentle daily cleanser;
- The CBD Bio Tech Live Oxygen Toner that hydrates the skin and balances oil, while minimizing pores;
- The CBD Bio Tech Live Oxygen Facial Lotion, a light daily moisturizer; and
- The CBD Bio Tech Live Oxygen Cream that provides a protective layer over the skin

In addition to the luxury Live Oxygen Series, CBD Biotech is launching the CBD Biotech Magnetic Mask, a leading-edge mask that utilizes magnet technology to create a low-grade electromagnetic current, which may help to rejuvenate when combined with its own blend of soothing, hydrating anti-inflammatory ingredients. 

Summer Yun, CEO of CBD Biotechnology Co., Ltd., comments, "The growing Chinese middle-class has shown a desire for luxury skincare products. CBD Biotech is meeting market demands by offering cutting-edge products that use the latest skincare technologies and include our exclusive hemp infused formulas."

"CBD Biotech is establishing itself as a leader in the new hemp-infused skincare market in China and intends to grow its market share in the industry by continuing to expand its product lines, developing new, innovative products for target markets, and growing its online following through well-known, Chinese beauty influencers," he added.

SAN GABRIEL, California, December 13, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (OTCQB: CIIX) ('CIIX' or the 'Company'), the premier financial information website for Chinese-speaking investors, today announces plans to spin off its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., and its wholly-owned subsidiary, ChineseHempOil.com, Inc., to be registered as a separate publically traded company allowing CIIX to focus on its new Cryptocurrency Division and its Core Financial Education Business. The Company's Board of Directors approved plans to spin off the Consumer Products Division in both the United States and China, which includes its hemp oil assets and its new wholesale alcohol distribution business, at the end of February 2018. The Company will take appropriate steps for the shares of the subsidiary's common stock to be listed for trading on the OTC:QB. The Company hopes to emulate the success it experienced in incubating Medicine Man Technologies, Inc. ("MDCL") as it transitioned from a private startup company to successful public company. 

"We are excited to announce our intention to spin off CBD Biotechnology and ChineseHempOil.com, Inc. as we believe the existing business lines and the new acquisitions in China, secured by CEO Summer Yun, will allow these entities to continue to grow in their respective markets, while bringing new value to the Company's existing shareholders. The details about the value to the Company's existing shareholders will be announced in the coming weeks," says ChineseInvestor.com, Inc.'s CEO Warren Wang. 

CBD Biotechnology Co. Ltd. has recently acquired a Wholesale Alcohol License in China thereby expanding its Chinese consumer division to include distribution of "baijiu," the grain liquor known as the toast of choice for the Chinese. On November 7, 2017, CBD Biotechnology was issued Wholesale Alcohol License from the ShangHai Wine Monopoly Bureau effective October 24, 2107 for a three year term. 

CBD Biotechnology has also entered into a wholesale agreement with China GuiZhou HanTai Wine, Inc. to distribute its brand of baijiu, Yantai 1985, and has kicked off its sales and marketing plan by partnering with Jinri Toutiao (translation: Today's Headlines), a popular Chinese mobile application just in time to launch for the Chinese New Year.  Founded in 1979, China GuiZhou HanTai Wine, Inc.'s top-selling baijiu brand, Yantai 1985, is produced in the town of Maotai in China's Guizhou province. Moutai is renowned for having the purest water in China; therefore, spirits produced in Moutai have a distinct taste and pleasing aroma attributable to the use of local water in the production.

Today's Headlines, the first broad news aggregator app in China, with content ranging from real-time news to music, movies, games, and shopping, is one of the most popular and fastest growing mobile apps in China with over 600 million registered users.  Today's Headlines provides CBD Biotechnology a cost effective, convenient, and trustworthy platform to directly connect with millions of users to market Yantai 1985, the CBD Magic Hemp Series skincare line and other complimentary consumer product lines it may identify in the near future. Reports indicate that online sales of alcohol beverages in China will double by 2020 as more consumers look for product information online before buying. Through its relationship with China GuiZhou HanTai Wine, Inc. and Today's Headlines, CBD Biotechnology hopes to capitalize on this growing consumer trend to expand its brand awareness and achieve sustainable revenue growth.

According to Summer Yun, CEO of CBD Biotechnology Co. Ltd., "The decision to expand CBD Biotechnology's Chinese Consumer Division to include baijiu liquor sales is part of a strategic plan to increase revenues in the coming year. By aligning with China GuiZhou HanTai Wine, Inc., CBD Biotechnology has partnered with a proven leader in the Chinese baijiu market. In addition to distribution rights, the agreement between CBD Biotechnology and China GuiZhou HanTai Wine, Inc. affords CBD Biotechnology the opportunity to launch its own brand of baijiu in the future." Ultra-premium baijiu volumes are expected to jump by 16% a year over the next five years as the number of high earners in China soars, a new report has said, providing CBD Biotechnology a huge opportunity to gain significant market share in this growing industry.

SAN GABRIEL, California, December 5, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, announced today that it has entered into an agreement with Blockchain BTM, LLC to host a Bitcoin ATM at its San Gabriel, California office with plans to expand to serve other Chinese Communities throughout the United States. The Bitcoin ATM, located in the lobby of the Company's offices in the highly trafficked San Gabriel Hilton Plaza, is open from 9 a.m. to 6 p.m., Monday through Friday, making it convenient and easy to purchase Bitcoin. Purchasers will have access to on site customer service representatives available to provide instruction regarding the Bitcoin ATM in both Chinese and English. The machine however offers translation into five languages including traditional and simplified Chinese, English, Spanish, French and Korean.

Cryptocurrency enthusiasts can purchase up to $7,000 worth of Bitcoin daily from the ATM. If the purchaser does not already have a digital wallet to hold the cryptocurrency, the ATM is able to digitally print a wallet. Alternatively, there are many digital wallet smartphone apps available for download for Android and iPhone. For those that wish to make a more significant investment, over $7,000, the Company can provide information on how to facilitate much larger transactions.

In recent weeks the Company unveiled its new cryptocurrency education and information services, including the first Chinese Daily Video Newscast, Bitcoin Multimillionaire, broadcast from the NYSE covering Cryptocurrency and Blockchain Technology. In November the Company launched a free bitcoin news and education website in the Chinese language under the domain name newcoins168.com to serve Chinese cryptocurrency investors globally. In addition, the Company will launch new cryptocurrency subscription products in January 2018.

"Although there has been some volatility in the cryptocurrency market, Bitcoin's price resilience is impressive, reaching over $11,000.00 in the last week, with a Friday close of $10,814. With each rebound in price relative to news, we see more evidence that the concept of digital currency is taking root with investors and the general public alike," says Warren Wang, Founder and CEO of CIIX. "In addition to providing skilled investors with news about digital currency, ChineseInvestors.com, Inc. hopes to satisfy the average person's curiosity about cryptocurrency, including how to purchase Bitcoin. Moreover, the underlying Blockchain Technology is extremely compelling and we expect to see many interesting developments in this area. Bitcoin ATMs are just one example of how this area is moving forward. We are excited to make this service available to the Chinese community."

SAN GABRIEL, California, November 16, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced that its wholly owned subsidiary, ChineseHempOil.com, Inc., launched its OptHemp product line on Amazon.com kicking off a multi-channel campaign geared to both the US and Chinese-American markets during the 9th annual Singles Day Celebration.

This commences the e-commerce marketplace initiative that the Company set into motion in early June through a strategic partnership with a top 100 platinum level partner seller on Amazon Marketplace that has agreed to include the OptHemp product line in its limited catalog for resale through the Amazon Channel. This partnership brings to the OptHemp product line, the full weight and power of a national sales and marketing agency that specializes in providing business solutions including headquarter sales services, analytics, insights and intelligence, retail services, marketing, digital technology and business process outsourcing. The OptHemp products launched on Amazon.com represent the Company's first use of Amazon for product sales.

"We are excited about the Amazon launch for Singles Day, 11/11/2017. Guanggun Jie which translated literally means 'Single Sticks' Holiday' is an entertaining festival widespread among young Mainland Chinese people, to celebrate being single. This festival has become one the largest offline and online shopping days in the world, and as it has morphed into a global shopping holiday in the last several years; therefore, we thought it was the perfect day to launch with Amazon.com in advance of the holidays," said Warren Wang, CEO of ChineseInvestors.com, Inc.

The Company also has plans to launch two new, first-of-their-kind products that will be available on Amazon.com before the Black Friday and Cyber Monday shopping extravaganzas. With two product lines launching on Amazon.com, the Company hopes to make the most of the upcoming holiday buying season positioning itself to earn generous revenues.

NEW YORK, NY--(Marketwired - Sep 29, 2017) -  NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ChineseInvestors.com, Inc. ( OTCQB : CIIX ), a client of NNW recognizing unprecedented opportunities in the U.S. cannabis industry and laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

The publication is titled, "Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market." It discusses various public companies across multiple sectors that are getting their share of the profitable marijuana market.

SAN GABRIEL, California, September 26, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced that it has appointed Paul Dickman as its Chief Financial Officer ("CFO") effective September 26, 2017. Mr. Dickman will also continue to serve on the Company's Board of Directors. As ChineseInvestors.com, Inc.'s new CFO, Mr. Dickman is responsible for leading financial operations and activities for the Company and establishing and monitoring the financial plan and strategies for the Company.

Mr. Dickman previously served as the Company's CFO from July 2010 through October 22, 2016, when he resigned to pursue a new opportunity. Upon his resignation as CFO, Mr. Dickman continued to remain a part of the Company's leadership team serving as a non-employee member of the Board of Directors and as the chairman of several committees.

Mr. Dickman has a broad range of accounting and finance experience. He began his career working as an auditor and financial consultant with several regional accounting and consulting firms. His previous roles include working on large private and public organizations as well as fraud investigations and preparing complex business valuations. In addition to his work as CFO for Chineseinvestors.com, Inc., he has also served as the CFO for several other companies which he has led through the process of becoming publicly traded companies. Mr. Dickman is an entrepreneur and has successfully built businesses from the ground up, as well as being an active investor in the angel community. Mr. Dickman is also the founder and president of Breakwater MB, a boutique merchant bank focused on investing in high-growth businesses in emerging industries.

In addition to his work in finance, Mr. Dickman has extensive experience serving as a governance expert and board member. In addition to serving on the board of Chineseinvestors.com, Inc. he has served on the board of the Rockies Venture Club, Medicine Man Technologies, Inc., as well as a local nonprofit board. During his time serving in these, capacities he has continued to develop this expertise for which he was recognized as a Fellow of the National Association of Corporate Directors (NACD).

"We are incredibly fortunate that Paul has agreed to return as our Chief Financial Officer. We look forward to his contributions in the financial and contractual management of the Company's growth. Moreover, Paul shares our passion for excellence, innovation, and entrepreneurial thinking," said Warren Wang, Chief Executive Officer. "I am confident that Paul will serve effectively as our CFO just as he did in the past, helping us to build an infrastructure that supports long-term growth."

"I am excited to resume the position as CFO for ChineseInvestors.com, Inc.," said Paul. "Over the next few years, we will work together to identify the greatest opportunities for growth and develop and adopt strategic solutions to achieve our growth goals for the upcoming year."

Paul received his Bachelor of Science in financial management from Bob Jones University. He is currently a licensed CPA in the state of South Carolina.

SAN GABRIEL, California, September 18, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ('CIIX' or the 'Company'), the premier financial information website for Chinese-speaking investors, today announces that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has completed the record filing process with the China Food & Drug Administration ('CFDA') for its first line of non-industrial hemp-infused skin care products. The Company expects to launch the 'CBD Magic Hemp Series' skin care line in the next couple of months positioning CBD Biotechnology as a leader in what it believes to be an untapped segment of China's skin care industry.

The initial ' CBD Magic Hemp Series' launch will include:

The CBDBIO TECH Brightening and Refreshing Moisturizer - intended to balance the skin's moisture, while forming a protective, moisturizing layer;
The CBDBIO TECH Perfecting Shield Primer - intended to even skin tone, while covering fine lines and minimizing the look of pores; and
The CBDBIO TECH Peptide Collagen Solution - intended to moisturize and firm the skin, while smoothing fine lines, and reducing signs of aging.
The 'CBD Magic Hemp Series' is different from other skin care lines currently available in China because the products are infused with hemp extract, otherwise known as cannabidiol or CBD. CBD, a powerful antioxidants and anti-inflammatory agent, has been widely used in skin care products in western countries for some time. Although a catalogue provided by the CFDA entitled 'Catalogue of Cosmetics Raw Materials in Use (2015)' includes Cannabis Sativa Leaf Extract, CBD Biotech is not aware of any other Chinese skin care manufacturers that have entered this emerging market, setting the stage for CBD Biotechnology to proudly take the lead with its innovative product line.

"I am very pleased to announce the upcoming launch of CBD Biotechnology's non-industrial hemp-infused skin care line, CBD Magic Hemp Series," says Summer Yun, CEO of CBD Biotechnology Co., Ltd. "We have not only completed the filing process with CFDA, but we have also contracted with a large processing factory in Shanghai, China, with over 14-years of experience in cosmetics production."

"China has one of the world's largest consumer markets for skin care products. Retail sales of cosmetics in China grew from 19.5 billion yuan in March 2016 to 21.49 billion yuan in March 2017," says Yun. "Moreover, online cosmetic sales in China grew 25% to an estimated 124 billion yuan in 2015. As one of the first hemp-infused skin care brands in China, we are confident that CBD Biotechnology will lead Chinese market, with potential for global expansion."

SAN GABRIEL, California, September 12, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today provides an update on its financial and business achievements for the fiscal year of 2017, as well as its outlook for fiscal year 2018. At the same time, Warren Wang, founder and CEO of CIIX, comments on the recent stock price volatility as it may relate to recent news in the Digital Currency Industry.

The fiscal year ended May 31, 2017 represents a significant milestone in the Company's 18-year history as both its long established Financial Services/Media Division, and the more recently established Consumer Division, have made substantial progress this year.

Financial Highlights:

Filed form 10K with the U.S. Securities and Exchange Commission (SEC) reflecting significantly higher revenues for the fiscal year ended May 31, 2017, as compared to fiscal 2016 with total operating revenues increased by 76%.
Revenues from both the investor relations business and the subscription business continued to grow this year, with an increase of 130% and 57% respectively.
Financial Services Business Highlights:

Upgraded the US stocks live video platform and revealed details of real-money trading conducted by all analysts to paid VIP subscribers.
Announced plans to launch a Cryptocurrency Education and Trading Subscription Service and the first Chinese daily video news broadcast from the NYSE covering digital currency and blockchain technology before the end of 2017.
Hemp Oil Business Highlights:

Established CBD Biotechnology Co., Ltd., a wholly-owned foreign enterprise in Shanghai, China; appointed Summer Yun as Chief Executive Officer (CEO); and announced plans to launch of its hemp-infused skin care line in China before end of 2017.
Established ChineseHempOil.com, Inc., a wholly-owned subsidiary in the US; launched its first hemp oil product line "OptHemp;" and appointed Keevin Gillespie as President.
Engaged Launch Haus, LLC, a venture building firm and digital holding company specializing in direct response marketing including digital, E-commerce and direct sales channels.
Retained Buyopsy, LLC, a wholly owned subsidiary of Launch Haus, LLC responsible for handling direct to consumer implementations and staff augmentation, and its Principal Chris J Snook (effective September 1, 2017) to provide day-to-day leadership in growth and E-commerce for ChineseInvestors.com, Inc., ChineseHempOil.com and CBD Biotechnology Co., Ltd.
"I am very pleased about the Company's significant increase in revenue in the fiscal year ended May 31, 2017," says Wang. "Although the blueprint of our Company's business strategy has expanded through its entrance into the Hemp Industry, our core subscription and investors relations services remain strong with significant growth rates. I am thankful for the investors who have supported our ongoing development plans and look forward to a prosperous year ahead."

Looking forward, Wang states, "although the business of our Consumer Division is still in the early stages, the recently launched 'OptHemp' product line is gaining popularity among Chinese consumers in the US, and the Company's first hemp-infused skin care product line will launch in China in the coming months. We believe that through the efforts of our business strategists such as Buyopsy, LLC and its principal Chris Snook, our E-commerce partners such as Elevated.com and Quiverr.com, and our talented management team, we will generate substantial revenues in FY 2018 via sales of our hemp-based products in the United States and China. Our overall goal in 2018 is for the Company is to achieve annual revenue growth of more than 100%, while cutting costs and achieving profitability."

The Company recently announced that its Financial Services/Media Division will also be providing ancillary services in the popular Digital Currency Industry.  Digital Currency has attracted a lot of attention in recent years from the creation of Bitcoin, the world's first decentralized digital currency, to blockchain technology, which allows digital currency to transfer value across the globe without resorting to traditional intermediaries such as banks.  This industry has also created new phenomena such as currency mining, trading, tender, and storage related businesses and has paved the way for companies such as ChineseInvestors.com, Inc. to provide its educational subscription services to the many market investors that see the unique opportunity that digital currency poses and that desire to capitalize on this market opportunity. These interested investors may not have a full understanding of the concept of digital currency or access to the latest market news; therefore the Company sees this as an opportunity to provide fundamental knowledge to Chinese speaking newcomers to digital currency, including straightforward explanations of the basics of digital currency, how to buy it and straightforward trading guidelines.  For those with digital currency experience, the Company will provide more detailed information regarding currency mining, blockchain technology, stock trends and ETFs. As part of its plan to enter the Digital Currency Industry, the Company also recently announced its plans to launch a Chinese Daily Video News Broadcast from the NYSE floor covering the Digital Currency Market. 

"The Company is excited about the opportunity to enter the Digital Currency Market as an ancillary service provider," says Wang. "Although the Company's stock price may have recently been affected short term due to recent news in the Digital Currency Industry, as an ancillary service provider the Company does not anticipate that it will be affected long term by the ban prohibiting Chinese exchanges from providing digital currency trading services, Chinese regulators' efforts to limit the use of digital currencies, the recent release by Chinese authorities declaring initial coin offerings ("ICOs") illegal in China, or the US SEC's warnings that securities laws apply to ICOs.  While these regulatory measures and the recent global news surrounding digital currency exchanges may slow the interest surrounding digital currency and ICOs, they may also make the terrain more reliable and safer for investors. Moreover, with large investors becoming more involved in the Digital Currency Market, we believe that the need to overcome the limitations of digital currency exchanges has become imperative. Although CIIX does not currently have plans for an ICO, we are excited about the opportunity to expand our subscription services and media services division on the opportunities that we expect to emerge from the Digital Currency Market."

"However, CIIX has neither set up a cryptocurrency exchange in China, nor raised capital through an ICO. Some investors have a misunderstanding of our business," clarifies Wang.

NEW YORK, NY--(Marketwired - Sep 8, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ChineseInvestors.com, Inc. ( OTCQB : CIIX ), a client of NNW recognizing unprecedented opportunities in the U.S. cannabis industry and laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

The publication, entitled, "Public Companies Taking Part in the Cryptocurrency Evolution," discusses the broader cryptocurrency market and how several publicly traded companies are taking advantage of industry growth.

SAN GABRIEL, California, August 14, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces the launch of its cryptocurrency education and trading subscription service on Chinesefn.com, the Company's dynamic financial website that provides real-time market commentary, analysis, and educational related services to Chinese-speaking investors. The new subscription service will cover timely news and will provide analysis regarding all aspects of the emerging digital currency world, including coverage of cryptocurrencies including bitcoin and ethereum, industry trends, price movement, sector related stocks and ETFs, etc.

Cryptocurrency has attracted a lot of attention in recent years from the creation of bitcoin, the world's first decentralized digital currency to blockchain technology, which allows cryptocurrency to transfer value across the globe without resorting to traditional intermediaries such as banks. The ability to transfer value solely through software is a huge breakthrough. The cryptocurrency market has also created new phenomena such as currency mining, trading, tender, and storage. At the same time, it has significantly impacted industries such as cybersecurity, cloud computing and storage, and semiconductors. 

"Cryptocurrencies like bitcoin have become a global phenomenon," says Warren Wang, Founder and CEO of CIIX. "Since January 2015, the price of Bitcoin has increased 500% from $200 to $1,000 in January 2017, and just spiked to a record high over $4,000 as US-North Korea tensions escalated. Likewise, ethereum has surged from less than $10 to more than $300 this year.

With the use and trading of cryptocurrencies on the rise in Asia, it appears that a much wider adoption of digital assets may be right around the corner. With an estimated 85% market share, China is one of the dominant players controlling bitcoin volume, along with Japan (which recently legalized bitcoin as a form of payment) and the United States. While many see the unique opportunity that cryptocurrency poses for investors and desire to capitalize on this market opportunity, they may not have a full understanding of the concept of digital currency or how the system works. CIIX intends to provide fundamental knowledge to Chinese speaking newcomers to cryptocurrency, including straightforward explanations of the basics of cryptocurrency, how to buy it and straightforward trading guidelines. For those with cryptocurrency experience, the Company will provide more detailed information regarding currency mining, blockchain technology, stock trends and ETFs. Through its innovative cryptocurrency education and trading subscription service, the Company endeavors to be the leading Chinese educational site providing up to date news and information on digital currencies."

SAN GABRIEL, California, July 24, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA). The new 'CBD Magic Hemp Series' skin care line is expected to launch between late August and early September 2017, positioning CBD Biotechnology as a first-mover in an untapped segment of China's skin care industry.

CBD (cannabidiol) is a non-psychoactive cannabis compound. Although ancient Chinese recognized the medicinal properties of the cannabis plant, CBD extract appears to be largely unrecognized in China today for its benefits, including but not limited to, its potential benefits to the largest visible human organ, the skin. The effects of increased air pollution on the human body are a growing concern for many in China. With regard to our skin, toxins in air pollution promote the production of free radicals, causing premature aging including coarse wrinkles and dark spots. However, some dermatologists believe that the anti-oxidants and anti-inflammatory agents in CBD can potentially have anti-aging effects on the skin.

Recognizing the untapped market potential, CBD Biotechnology is developing and manufacturing what it believes to be the first line of non-industrial hemp-infused skin care products in China in hopes of educating the Chinese population on the potential benefits of CBD for skin care. 

"I am very pleased to announce the upcoming launch of CBD Biotechnology's non-industrial hemp-infused skin care line," says Summer Yun, CEO of CBD Biotechnology Co., Ltd. "As one of the first skin care products containing CBD extract marketed in China, CBD Magic Hemp Series expects to capture 100% of China's market share in this novel skin care products category. Although a catalogue published by the CFDA, indicates that cannabis sativa leaf extract can legally be added to skin care products, it appears that Chinese skin care manufacturers have not yet entered this market, enabling CBD Biotechnology's skin care products to proudly take the lead with its innovative product line."

The 'CBD Magic Hemp Series' will include: 

- The CBD Peptide Collagen Solution - intended to moisturize and firm the skin, while smoothing fine lines, and preventing premature aging;

- The CBD Perfecting Shield Primer - intended to even skin tone, while covering fine lines and minimizing the look of pores; and

- The CBD Brightening and Refreshing Moisturizer - intended to balance the skin's moisture, while forming a protective, moisturizing layer.

"Consumption of skin care products per capita in China has increased from 169 Chinese Yuan Renminbi ("CNY") to 352CNY during the last five years," says Yun. "China has the world's second largest consumer market for skin care products, with its current market size already exceeding 300 billion CNY. The CARG (compound annual growth rate) of the skin care products market in China is 9.1%, more than double the global average of 4.1%. CBD Biotechnology will benefit from this large consumer market in China becoming one of the first companies in China to infuse its skin care products CBD extracted from non-industrial hemp."

SAN GABRIEL, California, June 28, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., will officially launch its first line of non-industrial hemp infused skin care products, the "CBD Magic Hemp Series." The product line will include four products, namely, CBDBIO TECH Toner, CBDBIO TECH Rejuvenating Cream, CBDBIO TECH Perfecting Shield Primer and CBDBIO TECH Rejuvenating Spray.

Air pollution is a concern for many people, especially in heavily populated cities, and the effects of such pollution on our health appear to have intensified. The air is filled with a variety of pollutants including cigarette smoke, car exhaust, smog, dirt, dust, and other particulates that contribute to mitochondrial oxidative stress which promotes the production of free radicals that have been linked to premature aging. Clinical studies found that women who live in urban areas with high levels of pollution had a 22 percent increase in pigmented spots and significantly more coarse wrinkling.  Some dermatologists contend that medicinal ingredients in cannabis offer the potential to make skin look younger. Specifically, cannabinoids are powerful antioxidants and anti-inflammatory agents.  Moreover, the endocannabinoid system consists of many cannabinoid receptors, and a large portion of these are found in the skin. Although cannabis is still illegal in China, Cannabis Sativa Leaf Extract can legally be added to skin care products. A catalogue provided by the China Food and Drug Administration entitled "Catalogue of Cosmetics Raw Materials in Use (2015)" includes Cannabis Sativa Leaf Extract.

The new skin care line is expected to be launched in the third calendar quarter of 2017.  CBD Biotechnology Co. Ltd. plans to use multiple sales channels to implement its sales plan including Tmall, TaoBao, the Company's official website, broadcasting platforms of internet celebrities, mobile news applications, and a multi-level direct selling system in cooperation with Shangdong Yibao Biologics Co. Ltd.

"Following the launch of OptHemp Ultra Premium Hemp Oil by CIIX's wholly owned U.S. subsidiary, ChineseHempOil.com, Inc., I am very pleased to announce the launch of CBD Biotechnology Co., Ltd. non-industrial hemp infused skin care line," says Summer Yun, CEO of CBD Biotechnology Co., Ltd. "CBD Biotechnology Co., Ltd. will be one of the first companies in China to incorporate hemp-based CBD into skin care products, which we believe will spark public interest.

"An estimated 55,700 metric tons of industrial hemp are produced around the world each year with China, Russia, and South Korea leading in production, accounting for 70 percent of the world's industrial hemp supply. Although China is one of the leading producers of industrial hemp, the benefits to the human body have not yet been widely recognized in mainland China," says Yun. "As one of the companies  company to introduce a skin care line infused with hemp-based CBD to China, CIIX looks forward to educating the almost 1.4 billion people in China about the benefits of hemp-based CBD and the positive effects it can have on the largest, visible human organ - the skin!"

SAN GABRIEL, California, June 14, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. CBD Biotechnology Inc. will focus on research, development and distribution of health products, including hemp-derived cannabidiol ("CBD") products, as well as hemp-based food and beverage products.

In April 2017, fulfilling a campaign pledge, Prime Minister Justin Trudeau introduced legislation to legalize the recreational use of marijuana in Canada by the middle of 2018. Canada will become the second country to completely legalize marijuana as a consumer product. The law will require purchasers to be at least 18 years old, and it will limit the amount they can carry at any one time to 30 grams. While the federal government will license and regulate growers, each of Canada's provinces will need to decide exactly how the drug will be distributed and sold within its boundaries.

"I am delighted about the incorporation of CBD Biotechnology Inc.," says Warren Wang, founder and CEO of CIIX. "CBD Biotechnology Inc. is strategically located in British Columbia, Canada, known to be a cannabis friendly province. The British Columbia cannabis industry produces 40 percent of all Canadian cannabis, making cannabis among the most valuable cash crops in the province. While CIIX has been laying the groundwork to enter the legal cannabis market for some time, the complete legalization of cannabis in Canada provides another great opportunity for CIIX to enter the market."

"The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health," concludes Wang.

SEATTLE, WA--(Marketwired - Jun 9, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing ChineseInvestors.com Inc. ( OTCQB : CIIX ) and its recent expansion into the multi-billion dollar legal hemp industry.

Building a Strong Core
ChineseInvestors.com was founded in 1999 by Mr. Wang Warren for Chinese-speaking investors in the United States and China. In the past, Mr. Warren participated in the initial placement and funding of Shopping.com that was later acquired and returned his investors 300% in three years. Later, he was instrumental in developing the marijuana consulting firm, Medicine Man of Denver, and returned investors 500% in three years.

Chief Technology Officer Kevin GE has also been working with ChineseInvestors.com since its incorporation in 1999. GE has over 18 years of experience in the IT industry and extensive experience in project development and management. He previously served as a Senior Programmer for Dynamic Systems and a Senior Consultant for yDebts Inc. And finally, independent director Paul Dickman brings a wealth of finance experience into the fold.

The company's core operations include real-time market commentary, analysis, and educational services in Chinese language for retail investors. In addition, the company provides consulting services to private companies considering going public, including advertising, public relations, and related support services. These activities have resulted in a database of approximately 100,000 registered high net worth native Chinese speaking investors worldwide

Expansion into the Hemp Industry
The U.S. hemp-based cannabidiol (CBD) market is projected to grow from $90 million in 2015 to $450 million by 2020, according to The Hemp Business Journal, making it one of the largest subsets of the legal cannabis industry. This growth is driven by the combination of increasingly health-conscious consumers and a growing body of research showing the potential benefits of CBD oil in addressing a wide range of medical conditions.

The company believes that China's hemp-based CBD industry could be even larger with more than 1.4 billion people and a historical preference for traditional medicines. In January, the company formed a wholly-owned subsidiary, CBD Biotechnology Co., Ltd., to operate ChineseCBDOil.com, added ChineseHempOil.com in April to operate online and retail sales of hemp-based health products in the U.S., and aims to open its first wellness center in June.

The company announced plans to further these efforts by partnering with a well known venture building firm, Launch Haus LLC, to develop a multi-level marketing platform and recruit top producers in the direct sales industry. Launch Haus has a strong presence in the direct-selling industry and its principals have a proven track record having built sales organizations with an excess of $1.5 billion in commissionable volume over the last 10 years. Concurrently, Chineseinvestors.com is launching a media campaign on the largest U.S. Chinese TV (PSTV), the largest Chinese portal in the U.S. (SINA), and various social media and print publications to raise awareness and increase sales.

SAN GABRIEL, California, May 24, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that Chinesehempoil.com Inc., established last month as a wholly owned subsidiary of CIIX, will officially launch its own premium hemp health product line 'OptHemp,' which will include the Company's first private label product, OptHemp Ultra Premium Hemp Oil.

SAN GABRIEL, California, April 24, 2017 /PRNewswire/ --

ChineseInvestors.com, Inc. (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today provides an update on its financial and business achievements for the third quarter of 2017, as well as its outlook for the remainder of the current fiscal year and 2018.

Financial Highlights:

Filed form 10Q with the U.S. Securities and Exchange Commission (SEC) reflecting significantly higher revenues for the three- and nine-month periods ended February 28, 2017, as compared to the same periods of fiscal 2016. Operating revenues increased 95% and 109%, respectively.
Revenues from the investor relations business continued to grow in the third quarter, accounting for approximately 60% of total revenues.

Business Highlights: 

Completed a $5 million private placement with proceeds to be allocated toward the development and branding of hemp-based health production line and retail sales operations; Shanghai & United States office expansions and infrastructure development, among other things.
Officially established and registered CBD Biotechnology Co. Ltd. ("XiBiDi Biotechnology Co. Ltd."), a wholly owned foreign entity of CIIX, in the Pudong Free-Trade Area in Shanghai.
Officially launched Chinese language online store ChineseCBDoil.com operated by CBD Biotechnology Co. Ltd., offering hemp-based health products to the Chinese community.
We have begun a private placement of a new series of our preferred stock offered only to Canadian investors.
In recognition of the unprecedented opportunities in the legal hemp industry, CIIX has expanded its business to capitalize on the growing demand for hemp-based health products via online and retail sales. As part of its expansion, the Company will focus on the operation of its new wholly owned foreign entity, CBD Biotechnology Co. Ltd. In addition earlier this month, the company established ChineseHempoil.com, Inc. and Hemp Logic, Inc. dba Hempstatic, both Delaware corporations, as subsidiaries of CIIX. Chinesehempoil.com, Inc. and Hemp Logic, Inc. are responsible for the development and operation of the online and retail sales of hemp-based health products in the United States. CIIX will soon open its first retail store in the predominantly Chinese community of San Gabriel, California, which is also the location of the Company's headquarters. CIIX also maintains its commitment to continue to grow its membership subscriptions and investor relations business.

According to our chief executive officer, Warren Wang, "Development of a line of our hemp-based health products, for the most part, is complete and preparation of related websites, retail channels and marketing campaigns are entering the final stages as well. The Company's hemp-based health products are expected to be available in the North American markets in the coming weeks. CIIX will continue to develop various hemp-based products for distribution and sale all over the world in hopes of helping people to improve their overall health, particularly in the Chinese community. I am grateful for to the investors who have supported our ongoing development plans and look forward to a prosperous year ahead."

Looking forward, Wang states, "The blueprint of our Company's corporate business strategy has changed as we are entering the legal hemp industry and because of this, our revenues this quarter did not exceed that of the previous quarter. However, revenues for the nine-month period increased by more than 100%. We believe our plan to market and sell hemp-based health products in the United States and China will generate substantial revenues for CIIX in FY2018. Our overall goal in 2018 is for CIIX to achieve annual revenue growth rate of more than 100%, while cutting costs and achieving profitability."

NEW YORK, February 13, 2017 /PRNewswire/ --

ChineseInvestors.com (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today provides an update on the Company's financial and business achievements in January 2017, as well as offers insight into plans moving forward.

"January represents a significant milestone in CIIX's 18-year history, and we are pleased to update shareholders on key highlights of our progress. This includes sequential revenue growth and our entrance into the hemp-based CBD oil industry," says CIIX founder and CEO Warren Wang. "I am grateful for investors who support our ongoing development plans and look forward to a prosperous year ahead."

January Financial Highlights:

We filed form 10Q with the U.S. Securities and Exchange Commission (SEC), reflecting significantly higher revenues for the three- and six-month periods ended November 30, 2016, as compared to the same periods of 2015. Operating revenues increased 133% and 121%, respectively.
With diversified revenue streams, CIIX successfully achieved revenue growth for three consecutive quarters.
January Business Highlights:

We completed a $5 million private placement for our Series C-2016 convertible preferred stock, the proceeds of which will be allocated to the development and branding of hemp-based cannabidiol (CBD) oil online and retail sales operations; to invest in growing hemp and producing hemp-based CBD oil products in China to yield greater production and sales margins; to invest in the pursuit of regulatory approval for use of hemp-based CBD oil products for specific health applications in Mainland China; and to invest in early-stage emerging public companies in the legal cannabis industry in Colorado, California and other states where legal.
Launched Chinese language site http://www.ChineseCBDoil.com to offer hemp-based CBD oil health products to the Chinese community in the United States and Mainland China.
Rolled-out a new Chinese language app, 'Da Ma Dian Ping', 大麻点评网 which provides crowd-sourced cannabis and CBD oil product reviews and location information for dispensaries and CBD retail stores in the United States.
Participated in various roadshows targeting mainstream American investors, including the Southern California Investment Forum, the South Florida Investment Forum, and NOBLE Capital Markets Institutional Investor Conference. Additionally, CIIX plans to attend the upcoming Disruptive Growth & Healthcare Conference in New York, the SeeThruEquity Microcap Investor Conference in Miami, and the National Investment Banking Association (NIBA) New York Conference.
Building on the traction of January's achievements, CIIX intends to focus on becoming a recognizable leader in the hemp-based CBD oil industry. The Company is hopeful that if the medicinal value of hemp-based CBD oil is accepted by Chinese regulatory authorities, the CBD oil that we help promote will find market acceptance among China's nearly 1.4 billion people. CIIX is reaching out to this market through http://www.ChineseCBDoil.com, and in upcoming months will open a retail store in the predominantly Chinese community of San Gabriel, California, also where the Company's headquarters are located.

"The hemp-based CBD oil market has great potential and our management team and employees are very excited to develop this new division of the company," says Wang. "Our longer term plans include opening additional brick-and-mortar retail locations in the U.S. and around the world."

In addition to continued growth of its online and retail distribution business, CIIX intends to invest in hemp-based CBD oil drug research and development enterprises in China.

"Our ultimate goal in this arena is to obtain regulatory approval for the use of hemp-based CBD drugs to combat Epilepsy and Alzheimer's disease. The application period for new drugs of this type in China is two to four years, much shorter than US Food and Drug Administration approval timelines. Our goal is to be the first company in China to use hemp-based CBD oil products to help mitigate the suffering of patients with Epilepsy and Alzheimer's disease," concludes Wang. As yet, neither the US Food and Drug Administration nor the Chinese drug regulatory authorities have accepted CBD oils to treat either disease.

NEW YORK, NY--(Marketwired - Jan 25, 2017) - ChineseInvestors.com, Inc. (the "Company") ( OTCQB : CIIX ), the premier financial information website for Chinese-speaking investors in both the U.S. and China, announces that it has engaged the expertise of NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW's solutions help public and private organizations find their voice and build market visibility via social media and a rapidly expanding distribution network of well over 5,000 key syndication outlets.

"ChineseInvestors.com has a strong history of providing investment-based education products and services. We are now taking significant strides to expand our operations and capitalize on the lucrative growth of the cannabis industry with the upcoming and previously announced launch of www.ChineseCBDoil.com," says Warren Wang, founder and CEO of CIIX. "This is an opportunity we certainly do not want to miss, and one that will require enhanced communication and transparency for existing and potential shareholders. At this time of incredible growth, we are pleased to partner with NNW to ensure effective and far-reaching communication to the investment community."

As part of the Client-Partner relationship between the companies, NNW will leverage its investor-based Brand Network of partners, various newsletters, social media channels, editorial articles, and other outreach tools to generate greater brand awareness for CIIX.

"CIIX has drawn specific blueprints to expand its focus to include the online sale of cannabidiol (CBD)-based nutrition and health products in China, a relatively untapped market with unseen potential," states Sherri Franklin, director of Content Marketing for NNW. "We are coming alongside CIIX at a time when effective communication is critical to success, reputation and corporate growth. We look forward to helping Warren's team build a presence in the cannabis industry while maintaining its long-standing position as a financial information website."

NEW YORK, December 5, 2016 /PRNewswire/ --

ChineseInvestors.com (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, today announced that it has entered into a new strategic alliance framework agreement with Shenzhen Yuanrong PE Capital ("Yuanrong"), a private capital firm based in China. Under the framework agreement, CIIX and Yuanrong will engage together in raising seed capital from mainland Chinese investors with the use of proceeds going to locating and funding select propitious investment opportunities in the new emerging industry of medical and recreational cannabis.

This new strategic alliance will target two types of enterprises. The first category includes Chinese manufacturers that export products to the US, such as companies focusing on soil-free indoor gardening, energy-saving LEDs, greenhouse engineering design and greenhouse hardware. CIIX and Yuanrong will provide the companies with the individual and institutional funds raised in China, assistance in becoming publically-traded in the US market, and investor relations services to improve their visibility and profitability. 

The second category includes companies that produce CBD oil, which is a natural, non-psychoactive concentrate extracted from cannabis. The use of CBD oil has been legalized in 50 states in the US, and it can also be exported to more than 40 countries including China. This concentrate can be widely used in nutrition supplements, skin care products, normal beverages and functional beverages and can be sold through either the traditional or direct sales method. Because China has a prospective consumer base of 1.5 billion people, whoever takes the first step to invest in these CBD oil manufacturers could have potentially towering profit opportunities. 

Warren Wang, founder and CEO of CIIX, commented: "According to recent projections from Cowen & Co., one of the most preeminent boutique investment firms on Wall Street, the legal cannabis industry in the U.S. is expected to be worth $50 billion by 2026, expanding to more than eight times its current size. In addition, investment banks focusing on the cannabis industry have increased from one to five during the latest year."

Mr. Wang further remarked: "Many manufacturers in China want to participate in the cultivation of cannabis, and the recent strength of the US dollar exchange rate provides a further advantage to Chinese manufacturers. However, investors from mainland China have little access to information and insights about the US cannabis industry. Fortunately, ChineseInvestors.com has a clear lead in early research of the cannabis industry compared to our other peers. Our investment in The Medicine Man Denver, Inc. (MDCL) was a great success over the last three years. We are very confident our new strategic alliance with Yuanrong will provide Chinese individuals and institutional investors with the researched news in 2017."

NEW YORK, November 21, 2016 /PRNewswire/ --

ChineseInvestors.com (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, announces today that it has appointed Kevin Ge to be its Chief Technology Officer (CTO), effective December 1st, 2016. Mr. Ge will report directly to CIIX CEO Warren Wang and oversee the Company's IT organization. His first major focus will be the launch and development of a cannabis "Yelp" style mobile application in the Chinese language that will contain a database of marijuana dispensaries and cannabis strains, a platform to review and discuss various cannabis products, and maps showing the locations of medical and recreational cannabis dispensaries.

Warren Wang, founder and CEO of CIIX, commented: "We are excited to officially appoint Kevin Ge as our CTO. Kevin is a technologist at heart and has 18-years of experience in creating and leveraging technology-based solutions that produce business value. California voters recently passed Proposition 64 to legalize recreational cannabis and voters in Massachusetts and Nevada passed similar referendums. Four other states including Florida legalized medical cannabis. We believe that the legal cannabis industry will expand to more than eight times its current size over the next 10 years and we intend to capitalize on this trend and launch the world's first ever cannabis 'Yelp' style social media mobile app in Chinese language."

Mr. Wang further remarked: "The demand for cannabis products in the Chinese population has the potential to be very significant. With the gradual opening up of cannabis industry in the United States, we feel confident that the Chinese community in the U.S. will eventually be persuaded to put aside their bias against the cultivation and sales of cannabis. And for those Chinese who already do accept medical or recreational use of cannabis, they will need help in locating appropriate resources to assist them in learning how to utilize cannabis in an effective way. Our new cannabis 'Yelp' style mobile app will be an indispensible tool for this new broad user base. Kevin has demonstrated a unique blend of strategic and technical ability and he is more than ready to accomplish the task of building platforms for cannabis retailers and local Chinese entrepreneurs that will help them cooperate with each other."

Kevin Ge, joined Chineseinvestors.com, Inc. in 1999 and serves as major programmer and system analyst since December 1999. Mr. Ge has also served as a Senior Programmer for Dynamic Systems, and a Senior Consultant for yDebts Inc. He has over 18 years of experience in the IT industry and has extensive experience in project development and management. He studied at Azusa Pacific University in Los Angeles where he received his Masters Degree in Computer Science.

NEW YORK, November 14, 2016 /PRNewswire/ --

ChineseInvestors.com (CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, announces today that it will launch the world's first Chinese-language mobile cannabis navigation application. This cannabis 'Yelp' style social media mobile app will contain a database of marijuana dispensaries and cannabis strains, a platform to review and discuss various cannabis products, and maps showing the locations of medical and recreational cannabis dispensaries. In addition, the mobile app will offer cannabis business summary reports of Los Angeles and other large cities, so that users can easily get the best recommendations for local legal marijuana products. The Company intends to launch this application on January 1st, 2017, and the platform will expand to include cannabis merchant advertising and tourism recommendations in the next few years.

By a margin of 56% to 44%, California voters passed Proposition 64 on November 8th, making it the fifth state to legalize recreational cannabis. With the addition of California, Massachusetts, Maine and Nevada, the percentage of Americans living in states where cannabis use is legal for adults rose from 5 percent to 20 percent. The approval of Proposition 64 implies that the legal cannabis industry in California will expand rapidly and cannabis trade revenues are expected to double in the coming year. The demand and popularity for legal cannabis products among Chinese communities have the potential to grow, as California has millions of Chinese in its population. Currently, there are about 1,250 cannabis retailers in the regions of Los Angeles and San Diego and the number is expected to grow after the legalization of recreational cannabis use.

Warren Wang, founder and CEO of CIIX, commented: "Many Chinese investors still have a bias against the cultivation and sales of cannabis, yet its effectiveness in the fields of medicine, food, cosmetics and other industries cannot be ignored. And for those Chinese who do accept medical or recreational use of cannabis, they will need help in locating appropriate resources to assist them in learning how to utilize cannabis in an effective way. The cannabis 'Yelp' style social media mobile app developed by our company is specifically designed to help curious Chinese people do this. Furthermore, this application will help Chinese investors discover valuable business opportunities in cannabis cultivation, advertising and tourism."

Mr. Wang further remarked: "With the gradual opening up of cannabis industry in the U.S., marijuana manufacturing and retail as well as research and development, will expand at a rapid pace. The legal cannabis industry in the U.S. is expected to be worth $50 billion by 2026, expanding to more than eight times its current size. We strongly believe that the current cannabis industry among Chinese communities can be considered as an emerging market. And we feel that our new cannabis navigation mobile application will bring more curious Chinese investors to this emerging market and more funding to the whole cannabis industry. CIIX will become the hub or most recognizable source for information and analysis among the Chinese cannabis consumer and investor."

NEW YORK, September 6, 2016 /PRNewswire/ --

ChineseInvestors.com (CIIX) is pleased to announce it has formed a strategic partnership with Tiger Brokers, the largest online financial brokerage in China.

Since its founding in 2015, Tiger Brokers has seen rapid growth in monthly trading with volume increasing to $800 million USD. 

ChineseInvestors.com has long been focused on serving Chinese investors in the North America market with core products like its VIP Livestream Membership Service, Dark Horse Trading Class and Educational Seminars. These products and services have been very well received by Chinese investors in both China and the US.

China-based investors in the US stock exchanges have reached a level of 1 million people this year, and that number is increasing annually as per Tiger Brokers research. CIIX and Tiger Brokers are seizing the opportunity to develop the market in China and CIIX is placing its VIP Livestream Membership Service and Trading Classes on the Tiger's online marketing system, thereby allowing CIIX's products to further penetrate the Chinese market.

Warren Wang, founder and CEO of CIIX, expressed his confidence in the new partnership with Tiger Brokers and further remarked: "CIIX will promote its VIP Livestream Membership Service and a series of training classes like the Dark Horse Trading Class. Customers who are interested in investing in the US exchanges will benefit from this strategic alliance. Tiger Brokers has been paying close attention to the influence of CIIX as our company continues to grow with Chinese traders in the US, and this strategic partnership will be mutually beneficial for both companies. I believe that Tiger Brokers have gained trust among China-based investors in the US exchanges and promoting CIIX's training products in their platform will meet these investors' needs. "

DENVER, Oct. 29, 2014 /PRNewswire/ -- ChineseInvestors.COM (OTCQB 'CIIX') was pleased with its first quarter results in generating a comprehensive profit of $147,501 on revenues of $644,787.  This represents a substantial improvement over the first quarter of FY 2014 that saw revenues of $525,011 and a comprehensive loss of ($5,842).

Mr. Warren Wang, Chairman and Chief Executive Officer commented, "I am very pleased with this quarter's earnings.  Based upon the current conditions of the general marketplace and interest expressed in our services, we expect to continue to post positive results for this year's performance."

Mr. Brett Roper, Chief Operating Officer commented, "As recently noted, we have spent a good deal of time this past year working with the ownership of Medicine Man Production Corporation in the creation of a new company, Medicine Man Technologies Inc. which holds by license assignment all of the experience and technical intellectual property of Medicine Man Production Denver, a Tier III cannabis industry cultivator/dispensary operator in Colorado.  After just three months of operations ending September 2014, this new business has entered into several licensing and consulting agreements with clients in Nevada, Illinois, and Florida.  It also has several prospective clients in Nevada, Arizona, Florida, Alaska, and New York noting ChineseInvestors.COM holds a substantial affiliate interest in this new business." 

Mr. Brett Roper continued, "Our support for this new business venture includes assistance for the coordination of a public company initiative for Medicine Man Technologies, Inc., noting that company has recently raised capital for this purpose as well as adding additional shareholders to its existing shareholder base in anticipation of this effort."  Mr. Roper serves as the Licensing Services Director and as an officer of Medicine Man Technologies, Inc.

Please note that "CIIX' has a fiscal year starting on June 1 and ending on May 31

DENVER, Sept. 16, 2014 /PRNewswire/ -- Completing its fiscal year in May, (FY 2014), ChineseInvestors.COM (OTC BB: CIIX) is pleased to announce a strong FY 2014 performance with substantial increases in its general year on year revenues as well as strong profitability.

Mr. Warren Wang, Chairman and Chief Executive Officer commented, "We have been working hard to improve our general support services delivery model for our clients this year and have seen those efforts handsomely rewarded.  Our revenues increased from $1.639M in FY 2013 to $3.902M in FY 2014 and what were operating losses of $1.118M for FY 2013 turned into profits of $1.149M in FY 2014.  As of the date of this press release our active service provider client list includes nine (9) OTCQB, and two (2) NYSE/NASDAQ companies, several of which have long term service agreements in place with us."

Mr. Wang added, "This performance represents earnings of approximately $0.18 per share, fully diluted for FY 2014 as compared with losses of $0.21 per share for FY 2013.  We are also working with several of our clients in support of their efforts to uplist to higher exchanges, noting one of our long term clients for which we provided such services to complete a successful uplisting effort (NASDAQ Global Markets) in January of this year."

Mr. Brett Roper, Chief Operating Officer commented, "We have spent a good deal of time this past year working with the ownership of Medicine Man Production of Denver in the creation of a new company, Medicine Man Technologies Inc. which holds all of the experience and technical intellectual property of Medicine Man Production Denver, a Tier III cannabis industry cultivator/dispensary operator in Colorado.  After just three months of operations this new business has entered into licensing and consulting agreements with one Nevada client and eight Illinois clients supporting multiple cannabis licensing applications in Illinois.  It also has several prospective clients in Nevada, Arizona, Florida, and New York and is already very profitable noting we are working to find the right public company solution for deployment for this new business in the near future."

DENVER, Feb. 28, 2014 /PRNewswire/ -- Just weeks after forming their new business venture, Medicine Man Technologies; Andy Williams, President of Medicine Man Denver and Brett Roper, Chief Operating Officer of ChineseInvestors.COM (OTCQB Symbol 'CIIX') are pleased to announce their first licensee client, McGraw Holdings, LLC of Illinois.

After extensive deliberation and consultation, McGraw Holdings, LLC, has chosen Medicine Man Technologies as its key service provider in bringing their extensive industry expertise and innovative business practices to the State of Illinois.  Expectations are that this new partnership will provide Illinois medical marijuana patients with the highest quality cannabis based products the market will have to offer.  The newly formed company will be submitting applications to allow construction of two technologically advanced marijuana grow operations, to be located in Illinois State Police Districts 5 and 21 in anticipation of fulfilling the supply needs of any of the potential 60 Illinois based dispensaries as proposed. 

Mr. Tim McGraw, owner of McGraw Holdings and managing partner of this new enterprise noted, "After touring dozens of facilities and interviewing their respective management teams, Medicine Man Technologies was our clear choice.  Mr. Andy Williams, his team, his experience, and extraordinary facilities are second to none in the industry.  In our opinion, we could not be more excited about building our new enterprise using his wealth of experience and success in Colorado to provide a steady supply of the highest quality medicine to patients in Illinois."

Mr. Andy Williams, Medicine Man's President and General Director of Medicine Man Technologies commented, "We are excited by this first of many opportunities to deliver our experience and highly evolved, variable capacity, continuous harvest process to this explosive growth-oriented space nationally.  We were also impressed with Tim's general business experience and the quality of his partners in this new business.  His construction as well as project management background add excellent value underpinnings as well."

LOS ANGELES, Feb. 18, 2014 /PRNewswire/ -- Moving forward into its third quarter (FY 2014), ChineseInvestors.COM (OTCQB Symbol 'CIIX') anticipates generating a solid increase in both the revenue as well as pretax earnings categories.

Mr. Warren Wang, Chairman and Chief Executive Officer commented, "We are very excited to see our third quarter performance shaping up so nicely.  We expect to substantially lower our lease space as well as interest expenditures while maintaining solid growth in all of our revenue categories.  Our service provider relationships are fueling our top line very nicely and as of the date of this press release our active service provider client list includes two (2) OTCPNK, eleven (11) OTCQB/X, and two (2) NYSE/NASDAQ companies; several of which have long term service agreements in place."

Mr. Brett Roper, Chief Operating Officer commented, "At this time we are projecting pretax earnings in the $500,000 range on revenues in the $1,100,000 range as related to Q3 of FY 2014 performance, noting that the quarter ends on February 28^th of 2014.  These values represent strong continued growth for the company and we are very excited by the recent announcement of our new venture with Medicine Man of Colorado in providing Cannabis related technology licensure.  We continue to work in providing various levels of support for 'private to public' as well as 'up listing' based company initiatives.  One of our long term OTCQB clients was just approved in January for elevation to the NASDAQ Global Markets Exchange."

Mr. Wang stated, "This pretax earnings forecast would place us at $0.06 per share in earnings based upon a fully diluted shareholder base and comfortably on target for doubling last year's top line while establishing a strong positive pretax earnings margin in comparison to last year's pretax losses (FY 2013) of just over $1.1M."

Second Quarter 2014 Financial Results

• Operating income of $276,039 on revenues of $819,977; exceeding the projected performance as noted in their November 22, 2013 press release.
• $0.03 per share in comparison to losses of <$0.11> per share last year

Mr. Warren Wang, Chairman and Chief Executive Officer commented, "We are very pleased with this quarter's earnings posting of $0.03 per share in comparison to losses of <$0.11> per share last year as it related to our operations over the first two quarters of fiscal year 2013 and fiscal year 2014. Based upon the current conditions of the general marketplace and interest expressed in our services, we expect to continue to post positive results this year."

Mr. Brett Roper, Chief Operating Officer commented, "Several of our clients experienced substantial growth in both their share price as well as volume this past quarter and one of our long term OTCQB clients was just accepted to the NASDAQ Global Market Exchange. Based upon the clients in place and the interim sales of our subscription services, we expect both our revenues as well as profitability to be very stable as we wrap up the third quarter of this fiscal year and hope that our stock will respond positively to these substantially improved financial performance metrics."

LOS ANGELES, Sept. 3, 2013 /PRNewswire/ compared with last year's losses of <$2,206,158>.-- ChineseInvestors.COM (OTCQB Symbol 'CIIX') reported year end operating revenues increased by 82% to $1,639,373 as compared with last year's revenues of $897,105.  The Company's losses also decreased by 50%; to <$1,118,041> as Mr. Warren Wang, Chairman and Chief Executive Officer noted, "We have had continued success in growing our Business Service related offerings to date noting on May 1^st, 2013 we had only two active clients while as of the date of this press release we now have 13 active clients that in combination have generated $1M+ in stock (rule 144, restricted) and $240,000 in cash based payment revenues over the past four months.  Naturally, we accrue these values to the proper period in which they are earned but we are encouraged by this performance.  We continue to provide subscription products that have already begun to generate additional sales as we enter FY 2014.  We feel that these offerings in combination with our other products will help us to expand both our customer base as well as build stronger revenue sources for the Company."

Mr. Brett Roper, Chief Operating Officer commented, "We are very encouraged by the growth in our fourth quarter Business Services Revenues as they rose to $260,360 in comparison to the first three quarters total performance of $116,047.  We also were able to generate a balance sheet allowance improvement related to the same fourth quarter growth in our trading securities of $63,207 that is not reflected in our income statement numbers.  Our operating losses for the fourth quarter continue to shrink in comparison to our losses in the prior quarters of FY 2013 and we expect this trend to continue based upon the growth in our overall revenues.  Losses for the 1^st quarter of FY 2014 are expected to drop substantially as compared with those we experience in the prior quarter."

ChineseInvestors.com, Inc. ('CIIX'), founded in 1999 endeavors to be an innovative company; specializing in (a) providing real-time market commentary, analysis, and educational related endeavor(s) in Chinese language character sets (traditional and simplified), (b) providing support services to our various partners, (c) providing consultative services to smaller private companies considering becoming a public company, (d) providing various advertising as well as public relation support services, and (e) other services we may identify having the potential to create value or partnership opportunity with our existing services.

DENVER, March 27, 2013 /PRNewswire/ -- Over the weekend, ChineseInvestors.COM (OTCQB 'CIIX') CEO Warren Wangannounced that "We were pleased to hear that our client, Nova Lifestyle Inc. is continuing to grow its global presence with the announcement of terms for acquisition of the Bright Swallow International Group Limited.  This latest addition is particularly relevant to Nova's growing North American market share as it includes an excellent relationship with The Brick Limited, a 200+ furniture store chain serving Canada."

Mr. Wang further commented, "We expect to see continued growth in the overall revenue stream as they focus on expanding their product lines and locations globally.  Look for their annual report (10K) filing next week!"

ARCADIA, Calif., July 17, 2012 /PRNewswire/ -- ChineseInvestors.COM (OTCBB 'CIIX') announced today that its S-1 filing with the Securities and Exchange Commission became effective this past week, securing a $1.5M financing commitment from Kodiak Capital Group, LLC, a Delaware Limited Liability Company.

The Company's CEO, Mr. Warren Wang, noted, "I am very pleased to have this facility in place as it offers the Company (ChineseInvestors.COM and Chinesefn.com) access to additional funds that may be required in the future for various initiatives as well as operating capital.  It also serves as a vote of confidence for our business as we expand our operations in opening a Call Center in Shanghai and work to finalize our 1st major consulting agreement with a Chinese based manufacturer in assisting them to become public on the OTCBB later in 2013."

The Company's COO, Mr. Brett Roper, added that "We believe that these new opportunities will generate a significant increase in revenue potentials as associated with our newly formed Corporate Consulting and Services Division. This new undertaking is designed to assist other China-centric companies in their efforts to become public on the OTCBB and/or other markets."

Ryan Hobson, President of Kodiak Capital Group, LLC, a Delaware Limited Liability Company, stated, "Kodiak is pleased to be a part of the Company's capital needs strategy and looks forward to providing funds as stipulated under the terms of the funding agreement."

CIIX offers stock to take the company public. (Company was originally a private shell that became a non-public operating entity via a reverse merger).

Company Snapshot:

Specializes in providing real-time market commentary and analysis in Chinese

Use Of proceeds: